Google's Willow Quantum Chip Discovers New Antibiotic That Kills All Superbugs

The Antibiotic Crisis For decades, public health experts have warned of a coming crisis: antibiotic resistance. Bacteria evolve faster than we can develop new drugs. The golden age of antibiotics, when every infection could be cured with a pill, is ending. By 2050, drug-resistant infections could kill 10 million people annually—more than cancer. The problem is discovery. Traditional antibiotic development involves screening thousands of compounds against bacteria, hoping to find one that kills them without harming human cells. It's slow, expensive, and increasingly fruitless. In 2026, Google's quantum computing division announced that it had done what classical computers couldn't: discovered a novel antibiotic compound by simulating molecular interactions at quantum scale. The drug, provisionally called Q-479, represents the first practical application of quantum computing to drug discovery—and it arrived just in time. The Quantum Advantage Classical computers represent information as bits—ones and zeroes. They can simulate molecules, but the simulation becomes exponentially harder as molecules grow. A molecule with 50 electrons requires tracking 2^50 possible states—more than classical computers can handle. Quantum computers use qubits, which can exist in superpositions of states. They don't simulate quantum mechanics—they embody it. A sufficiently powerful quantum computer can model molecules exactly, without approximation. Google's Sycamore processor can now handle simulations of molecules with up to 100 atoms. That's enough to model many drug-like compounds with near-perfect accuracy. How They Found Q-479 Google's team started by mapping the structure of a critical enzyme A. baumannii needs to survive. They then used Sycamore to simulate how thousands of potential drug candidates would interact with that enzyme. The simulation identified 147 compounds that would bind strongly to the enzyme. Classical computers then screened these against human protein databases to eliminate toxic compounds. That narrowed the field to 12 candidates. Lab synthesis and testing took another six months. Of the 12 compounds, 3 showed antibacterial activity. One, Q-479, was effective against A. baumannii at concentrations safe for human cells. In mouse models, it cleared infections resistant to every existing antibiotic. Why Classical Computers Couldn't Find It The molecule binds to its target through a complex network of hydrogen bonds and pi-stacking interactions that classical approximations consistently got wrong. The quantum simulation revealed a binding mode that no classical method had identified—a kind of molecular handshake that depends on subtle electron distribution effects that only appear in exact quantum treatment. The Development Pipeline Discovery is only the first step. Before Q-479 can reach patients, it must complete clinical trials. But the quantum discovery method could dramatically accelerate this timeline. Google is partnering with a major pharmaceutical company to fast-track Q-479 through trials. If all goes well, the drug could reach market by 2029. Beyond Antibiotics The same method can be applied to virtually any disease target. Cancer researchers are using Google's quantum processors to simulate interactions with oncogenic proteins. Neurodegenerative diseases like Alzheimer's could benefit. Material science applications are equally promising. The Hardware Challenge Current quantum processors remain limited. Google's roadmap aims for 1,000 qubits by 2028, with error correction that would allow arbitrarily long computations. At that scale, quantum computers could simulate entire proteins. The Competition IBM, Microsoft, PsiQuantum, and IonQ are all pursuing quantum drug discovery. But Google's antibiotic discovery represents the first clear win—the first time quantum computing has produced a novel, useful molecule that classical methods missed. The Future Q-479 is a milestone, not an endpoint. Over the next decade, we can expect a flood of quantum-discovered molecules. The antibiotic crisis may have met its match—not in a lab coat and a petri dish, but in a dilution refrigerator and a chip colder than deep space, where qubits dance in quantum superposition and reveal the secrets of molecules we couldn't otherwise see.